Findings emerged from an analysis of data from 2588 men who participated in the REDUCE trial.
Short sleep duration is associated with a 47% increased risk of proteinuria, a surrogate marker for kidney disease progression.
After 6 months, researchers found a greater decrease in HbA1c levels compared to the control group.
In these patients, systolic blood pressure at night was elevated by an average of 2.9 mm Hg.
Chronic kidney disease found to be 58% more likely to develop in individuals with than without the sleep disorder.
Researchers find both common treatments produce modest BP decreases in sleep apnea patients.
Statins generally decrease aggression in men, increase aggression in postmenopausal women.
Correlation partially attenuated after adjustment for body mass index and change in weight.
Men who slept badly were twice as likely to suffer a heart attack and up to four times as likely to have a stroke.
Association between obstructive sleep apnea severity and glucose control in patients with untreated versus treated diabetes
Renal and Urology News Articles
- For Treating Uremic Pruritus, Evidence is Strongest for Gabapentin
- IgG-Degrading Enzyme Desensitizes, Permits HLA-Incompatible Transplant
- Evaluating Practice Options in the Shifting Health Care Landscape
- Melanoma Risk Higher in Kidney Transplant Recipients
- Kidneys From Octogenarian Donors Show Similar Survival
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)